Patents Assigned to Ascendis Pharma Inc.
  • Prodrugs comprising a pyroglutamate linker
    Patent number: 11298427
    Abstract: The present invention relates to novel prodrugs of primary or secondary amine-comprising biologically active moieties and pharmaceutically acceptable salts thereof, prodrug reagents, pharmaceutical compositions comprising said prodrugs and the use of prodrugs.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: April 12, 2022
    Assignees: Ascendis Pharma A/S, Ascendis Pharma Inc.
    Inventors: Harald Rau, Nicola Bisek, Samuel Weisbrod
  • Prodrugs Comprising a Pyroglutamate Linker
    Publication number: 20190216940
    Abstract: The present invention relates to novel prodrugs of primary or secondary amine-comprising biologically active moieties and pharmaceutically acceptable salts thereof, prodrug reagents, pharmaceutical compositions comprising said prodrugs and the use of prodrugs.
    Type: Application
    Filed: May 25, 2016
    Publication date: July 18, 2019
    Applicants: Ascendis Pharma A/S, Ascendis Pharma Inc.
    Inventors: Harald Rau, Nicola Bisek, Samuel Weisbrod